On Friday, Shares of Sabre Corp (NASDAQ:SABR), subtract -0.08% and closed at $26.16 in the last trading session. The last trading range of the stock ranges between $26.01 and $26.34. Sabre Corporation (SABR), the leading technology provider to the global travel industry and one of the world’s leading software companies, has opened up its inaugural Asia Pacific hackathon, 14 to 16 October, to also include virtual entries from the global developer community.
“We’ve received an overwhelming response to the declarement of our first ever Asia Pacific hackathon, with over 200 participants registered already from Singapore and the Asia Pacific region. We’ve decided to add the virtual entry component to meet demand from additional overseas developers seeking to take part but unable to join in person,” commented Roshan Mendis, senior vice president of Sabre Travel Network Asia Pacific.
Additional challenges have also been declared to run alongside the overall ‘Best New Technology Application’ category, which has a Grand Prize of US$10,000. These include ‘Best Use of Virtual Reality’, a ‘Chatbot Challenge,’ and travel merchandising challenges that showcase the New Sabre Red Workspace widgets, Sabre’s advanced platform for selling and booking travel which will launch in 2017.
Merrimack Pharmaceuticals Inc (NASDAQ:MACK), dropped -3.31% and closed at $4.96 in the last trading session. The last trading range of the stock ranges between $4.85 and $5.17. The company’s Market capitalization is $619.79 million with the total outstanding Shares of 129.24 million. Merrimack Pharmaceuticals, Inc. (MACK) recently declared final results from the pivotal Phase 3 NAPOLI-1 study validating the use of ONIVYDE® (irinotecan liposome injection) in combination with fluorouracil (5-FU) and leucovorin, which represents a new standard of care for patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) following treatment with gemcitabine-based therapy. The final NAPOLI-1 results were presented in a poster negotiation session and a separate analysis of NAPOLI-1 safety-over-time data was presented in a poster session at the European Society for Medical Oncology 2016 Congress in Copenhagen.
“The final results of the NAPOLI-1 study provide a high level of clinical evidence establishing the ONIVYDE regimen as a meaningful treatment option for patients with metastatic pancreatic cancer,” said Prof. Li-Tzong Chen, M.D., Ph.D., corresponding author, Investigator on the NAPOLI-1 trial and Director, National Institute of Cancer Research, National Health Research Institutes in Tainan, Taiwan. “Pancreatic cancer is a devastating disease with a poor prognosis. In a patient population with few treatment options, the ONIVYDE regimen provides an opportunity for extended overall survival while maintaining baseline quality-of-life and represents a new standard of care. We thank all of the patients, caregivers and investigators who take partd in this pivotal study.”
Banco Santander, S.A. (ADR)(NYSE:SAN), gained 1.87% and closed at $4.36 in the last trading session. The last trading range of the stock ranges between $4.36 and $4.43. The company’s Market capitalization is $65.84 Billion with the total outstanding Shares of 14.39 billion. During the 52-week trading session the minimum price at which share price traded, registered at $3.60 and reached to max level of $5.83. Santander Bank recently declared the grand opening of its newest branch in Philadelphia in the new Rodin Square complex located at 2103 Hamilton Street. To commemorate Santander’s newest branch and its fifth in Philadelphia’s Center City neighborhood, Santander will present checks totaling $12,000 to three community-based non-profit organizations — Affordable Housing Centers of Pennsylvania, Girard College and the Brewerytown-Sharswood Community Civic Association.
Santander executives will attend the grand opening celebration and ribbon cutting later recently to officially open the branch and present checks to representatives from each of three non-profit groups. Bank team members in addition to customers, community leaders and representatives from the Rodin Square complex development teams will also attend the event.
Angela Moultrie, Santander’s Region President for the Pennsylvania/New Jersey Central regions, commented, “With its favorable location and its modern, customer-focused design elements, our new Rodin Square branch is assisting to revitalize this area of Center City for residents and shoppers who appreciate the convenience of having amenities and services in one location.” She added, “Santander knows how important it is to be a good neighbor and invest in organizations that make up the fabric of the communities where we do business. The Affordable Housing Centers of Pennsylvania, Girard College, and the Brewerytown-Sharswood Community Civic Association each shares the Bank’s commitment to creating opportunities for those with limited financial resources and improving their quality of life through financial literacy counseling, education, small business development and neighborhood revitalization programs.”